The outlook of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key territories has introduced significant volatility. Investors are now facing the impact of lower-cost alternatives,